Bristol-Myers Squibb Credit Agreements

24 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amendment, dated as of June 22, 2021, to the Five Year Competitive Advance and Revolving Credit Facility Agreement dated as of July 30, 2012 among Bristol-Myers Squibb Company,...
Credit Agreements
Bristol-Myers Squibb
Pharmaceuticals
NY
2021
Extension Notice, dated June 1, 2021, for the Five Year Competitive Advance and Revolving Credit Facility Agreement dated as of July 30, 2012
Credit Agreements
Bristol-Myers Squibb
Pharmaceuticals
2021
Amendment and Waiver, dated as of June 22, 2021, to the Five Year Competitive Advance and Revolving Credit Facility Agreement dated as of September 29, 2011 among Bristol-Myers...
Credit Agreements
Bristol-Myers Squibb
Pharmaceuticals
NY
2021
Extension Notice, dated June 1, 2021, for the Five Year Competitive Advance and Revolving Credit Facility Agreement dated as of September 29, 2011
Credit Agreements
Bristol-Myers Squibb
Pharmaceuticals
2021
Amendment, dated as of January 22, 2021, to the Five Year Competitive Advance and Revolving Credit Facility Agreement dated as of July 30, 2012 among Bristol-Myers Squibb Company,...
Credit Agreements
Bristol-Myers Squibb
Pharmaceuticals
NY
2021
Amendment, dated as of January 22, 2021, to the Five Year Competitive Advance and Revolving Credit Facility Agreement dated as of September 29, 2011 among Bristol-Myers Squibb...
Credit Agreements
Bristol-Myers Squibb
Pharmaceuticals
NY
2021
Extension Notice, dated January 4, 2021, for the Five Year Competitive Advance and Revolving Credit Facility Agreement dated as of July 30, 2012
Credit Agreements
Bristol-Myers Squibb
Pharmaceuticals
2021
Extension Notice, dated January 4, 2021, for the Five Year Competitive Advance and Revolving Credit Facility Agreement dated as of September 29, 2011
Credit Agreements
Bristol-Myers Squibb
Pharmaceuticals
2021
Amendment and Waiver, dated as of June 17, 2020, to the Five Year Competitive Advance and Revolving Credit Facility Agreement dated as of July 30, 2012 among Bristol-Myers Squibb...
Credit Agreements
Bristol-Myers Squibb
Pharmaceuticals
NY
2020
Amendment and Waiver, dated as of June 17, 2020, to the Five Year Competitive Advance and Revolving Credit Facility Agreement dated as of September 29, 2011 among Bristol-Myers...
Credit Agreements
Bristol-Myers Squibb
Pharmaceuticals
NY
2020
Amendment, dated as of June 20, 2019, to the Five Year Competitive Advance and Revolving Credit Facility Agreement dated as of July 30, 2012 among Bristol-Myers Squibb Company,...
Credit Agreements
Bristol-Myers Squibb
Pharmaceuticals
NY
2019
Extension Notice, dated May 31, 2019, for the Five Year Competitive Advance and Revolving Credit Facility Agreement dated as of July 30, 2012
Credit Agreements
Bristol-Myers Squibb
Pharmaceuticals
2019
Amendment and Waiver, dated as of June 20, 2019, to the Five Year Competitive Advance and Revolving Credit Facility Agreement dated as of September 29, 2011 among Bristol-Myers...
Credit Agreements
Bristol-Myers Squibb
Pharmaceuticals
NY
2019
Extension Notice, dated May 31, 2019, for the Five Year Competitive Advance and Revolving Credit Facility Agreement dated as of September 29, 2011
Credit Agreements
Bristol-Myers Squibb
Pharmaceuticals
2019
Three-Year Revolving Credit Facility Agreement, dated as of January 25, 2019, by and among Bristol-Myers Squibb Company, the lenders party thereto and Morgan Stanley Senior...
Credit Agreements
Bristol-Myers Squibb
Pharmaceuticals
NY
2019
364-Day Revolving Credit Facility Agreement, dated as of January 25, 2019, by and among Bristol-Myers Squibb Company, the lenders party thereto and, Citibank, N.A. and JPMorgan...
Credit Agreements
Bristol-Myers Squibb
Pharmaceuticals
NY
2019
Extension to the Five Year Competitive Advance and Revolving Credit Facility Agreement dated as of July 30, 2012
Credit Agreements
Bristol-Myers Squibb
Pharmaceuticals
2018
Extension to the Five Year Competitive Advance and Revolving Credit Facility Agreement dated as of September 29, 2011
Credit Agreements
Bristol-Myers Squibb
Pharmaceuticals
2018
Amendment dated as of June 26, 2017, to the Five Year Competitive Advance and Revolving Credit Facility Agreement dated as of July 30, 2012 among Bristol-Myers Squibb Company, the...
Credit Agreements
Bristol-Myers Squibb
Pharmaceuticals
VA
2017
Amendment and Waiver dated as of June 26, 2017, to the Five Year Competitive Advance and Revolving Credit Facility Agreement dated as of September 29, 2011 among Bristol-Myers...
Credit Agreements
Bristol-Myers Squibb
Pharmaceuticals
NY
2017
FIRST AMENDMENT TO CREDIT AGREEMENT
Credit Agreements
Bristol-Myers Squibb
Pharmaceuticals
VA
2013
$1,500,000,000 FIVE YEAR COMPETITIVE ADVANCE AND REVOLVING CREDIT FACILITY AGREEMENT Among BRISTOL-MYERS SQUIBB COMPANY, THE BORROWING SUBSIDIARIES, THE LENDERS NAMED HEREIN, BANK...
Credit Agreements
Bristol-Myers Squibb
Pharmaceuticals
DE
2012
$1,500,000,000 FIVE YEAR COMPETITIVE ADVANCE AND REVOLVING CREDIT FACILITY AGREEMENT Among BRISTOL-MYERS SQUIBB COMPANY, THE BORROWING SUBSIDIARIES, THE LENDERS NAMED HEREIN, BANK...
Credit Agreements
Bristol-Myers Squibb
Pharmaceuticals
NY
2011
$2,000,000,000 FIVE YEAR COMPETITIVE ADVANCE AND REVOLVING CREDIT FACILITY AGREEMENT Among
Credit Agreements
Bristol-Myers Squibb
Pharmaceuticals
DE
2006